Literature DB >> 18929314

Sleep, insomnia and falls in elderly patients.

Katie L Stone1, Kristine E Ensrud, Sonia Ancoli-Israel.   

Abstract

Insomnia is common in older people and can be associated with significant daytime dysfunction. Sleep problems, and the medications used to treat them, may contribute to the risk of falls and fractures in this population; however, the independent effects of disturbed sleep or the risk of hypnotic use are not well understood. Data arising from the Study of Osteoporotic Fractures (SOF) cohort of elderly women have confirmed the link between sleep problems (measured subjectively or objectively) and an increased risk of falls after taking into account the use of insomnia medications (benzodiazepines) in a community-dwelling population of older women. The data also suggest that benzodiazepine use is associated with increased risk of falls, although this association is less clear-cut when insomnia/sleep problems are taken into consideration. The risk of falls should be considered when prescribing benzodiazepines in this population. So far no data exist concerning whether the effective treatment of insomnia in the elderly may help prevent falls. Furthermore, studies are warranted to evaluate the efficacy and safety of the non-benzodiazepine BZRAs (benzodiazepine receptor agonists) in relation to risk of falls. In addition, there is a need to include fall risk factors such as postural sway and reaction time as outcomes for trials of new insomnia treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929314     DOI: 10.1016/S1389-9457(08)70012-1

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  29 in total

1.  A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.

Authors:  Sonia Ancoli-Israel; Andrew D Krystal; W Vaughn McCall; Kendyl Schaefer; Amy Wilson; Raymond Claus; Robert Rubens; Thomas Roth
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

Review 2.  Impact of Poor Sleep on Physical and Mental Health in Older Women.

Authors:  Katie L Stone; Qian Xiao
Journal:  Sleep Med Clin       Date:  2018-09

Review 3.  The Relationship Between Diet and Sleep in Older Adults: a Narrative Review.

Authors:  Charlotte C Gupta; Christopher Irwin; Grace E Vincent; Saman Khalesi
Journal:  Curr Nutr Rep       Date:  2021-06-14

Review 4.  [Sleep disorders in the elderly : Importance in geriatrics].

Authors:  Helmut Frohnhofen; Nikolaus Netzer
Journal:  Z Gerontol Geriatr       Date:  2017-10-27       Impact factor: 1.281

5.  Use of clonazepam in REM sleep behavior disorder: association with fall-related injuries and alternative treatments.

Authors:  Vinícius Dokkedal-Silva; Lenise Jihe Kim; Priscila Kalil Morelhão; José Carlos Fernandes Galduróz; Sergio Tufik; Monica Levy Andersen
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

Review 6.  Insomnia in Elderly Patients: Recommendations for Pharmacological Management.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Drugs Aging       Date:  2018-09       Impact factor: 3.923

Review 7.  The effect of nocturia on sleep.

Authors:  Sonia Ancoli-Israel; Donald L Bliwise; Jens Peter Nørgaard
Journal:  Sleep Med Rev       Date:  2010-06-08       Impact factor: 11.609

Review 8.  Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review.

Authors:  Judith Sys; Simon Van Cleynenbreugel; Mieke Deschodt; Lorenz Van der Linden; Jos Tournoy
Journal:  Eur J Clin Pharmacol       Date:  2019-12-14       Impact factor: 2.953

Review 9.  Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person.

Authors:  Christine E Mc Carthy
Journal:  Med Sci (Basel)       Date:  2021-05-21

Review 10.  The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.

Authors:  Zanna J Voysey; Roger A Barker; Alpar S Lazar
Journal:  Neurotherapeutics       Date:  2020-11-11       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.